These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 20689814)

  • 1. IL-33 is produced by mast cells and regulates IgE-dependent inflammation.
    Hsu CL; Neilsen CV; Bryce PJ
    PLoS One; 2010 Aug; 5(8):e11944. PubMed ID: 20689814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine mast cells secrete and respond to interleukin-33.
    Tung HY; Plunkett B; Huang SK; Zhou Y
    J Interferon Cytokine Res; 2014 Mar; 34(3):141-7. PubMed ID: 24028396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible IL-33 expression by mast cells is regulated by a calcium-dependent pathway.
    Hsu CL; Bryce PJ
    J Immunol; 2012 Oct; 189(7):3421-9. PubMed ID: 22922818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
    J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-33/ST2 axis promotes mast cell survival via BCLXL.
    Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9.
    Hültner L; Kölsch S; Stassen M; Kaspers U; Kremer JP; Mailhammer R; Moeller J; Broszeit H; Schmitt E
    J Immunol; 2000 Jun; 164(11):5556-63. PubMed ID: 10820229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
    Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
    Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-33 primes mast cells for activation by IgG immune complexes.
    Kaieda S; Wang JX; Shnayder R; Fishgal N; Hei H; Lee RT; Stevens RL; Nigrovic PA
    PLoS One; 2012; 7(10):e47252. PubMed ID: 23071771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
    Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
    Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 induces Th17-mediated airway inflammation via mast cells in ovalbumin-challenged mice.
    Cho KA; Suh JW; Sohn JH; Park JW; Lee H; Kang JL; Woo SY; Cho YJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Feb; 302(4):L429-40. PubMed ID: 22180658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A20-deficient mast cells exacerbate inflammatory responses in vivo.
    Heger K; Fierens K; Vahl JC; Aszodi A; Peschke K; Schenten D; Hammad H; Beyaert R; Saur D; van Loo G; Roers A; Lambrecht BN; Kool M; Schmidt-Supprian M
    PLoS Biol; 2014 Jan; 12(1):e1001762. PubMed ID: 24453940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation.
    Ikeda K; Nakajima H; Suzuki K; Kagami S; Hirose K; Suto A; Saito Y; Iwamoto I
    Blood; 2003 May; 101(9):3594-6. PubMed ID: 12511410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent.
    Enoksson M; Möller-Westerberg C; Wicher G; Fallon PG; Forsberg-Nilsson K; Lunderius-Andersson C; Nilsson G
    Blood; 2013 Jan; 121(3):530-6. PubMed ID: 23093619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
    Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
    Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional Heterogeneity of Mast Cells and Basophils upon Activation.
    Chhiba KD; Hsu CL; Berdnikovs S; Bryce PJ
    J Immunol; 2017 Jun; 198(12):4868-4878. PubMed ID: 28476932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell-dependent IL-33/ST2 signaling is protective against the development of airway hyperresponsiveness in a house dust mite mouse model of asthma.
    Zoltowska Nilsson AM; Lei Y; Adner M; Nilsson GP
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L484-L492. PubMed ID: 29146574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-33 induces skin inflammation with mast cell and neutrophil activation.
    Hueber AJ; Alves-Filho JC; Asquith DL; Michels C; Millar NL; Reilly JH; Graham GJ; Liew FY; Miller AM; McInnes IB
    Eur J Immunol; 2011 Aug; 41(8):2229-37. PubMed ID: 21674479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-33 exacerbates antigen-induced arthritis by activating mast cells.
    Xu D; Jiang HR; Kewin P; Li Y; Mu R; Fraser AR; Pitman N; Kurowska-Stolarska M; McKenzie AN; McInnes IB; Liew FY
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10913-8. PubMed ID: 18667700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.
    Sandig H; Jobbings CE; Roldan NG; Whittingham-Dowd JK; Orinska Z; Takeuchi O; Akira S; Bulfone-Paus S
    Eur J Immunol; 2013 Apr; 43(4):979-88. PubMed ID: 23404570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.